A comprehensive study of oral oncolytic (anti- cancer) drug treatments revealed that while their use is increasingly common, cancer patients frequently face barriers to accessing oral drugs compared to those delivered intravenously in oncology practice settings. Source: General Cancer News Articles Provided by Cancer Compass